Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-04-10FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from ScieGen Pharmaceuticals, Inc.
-
FDA approval · 2026-02-27FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original abbreviated new drug application for diltiazem hydrochloride from Macleods Pharmaceuticals Limited.
-
FDA approval · 2026-02-23FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
The FDA approved a supplemental application for diltiazem hydrochloride from Zydus Pharmaceuticals USA Inc., approving a generic product.
-
FDA approval · 2026-01-18FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Slate Run Pharmaceuticals, LLC)
FDA approved a supplemental application for a generic diltiazem hydrochloride product from Slate Run Pharmaceuticals, LLC under an ANDA.
-
FDA approval · 2025-12-18FDA Approved: NICARDIPINE HYDROCHLORIDE — Supplemental Application (Chengdu Shuode Pharmaceutical Co., Ltd)
FDA approved a supplemental application for nicardipine hydrochloride by Chengdu Shuode Pharmaceutical Co., Ltd, indicating approval of a su…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-12-18FDA Approved: NITROGLYCERIN — Original Application (Solaris Pharma Corporation)
FDA approved the original application (ANDA) for Nitroglycerin by Solaris Pharma Corporation, establishing a generic product indication.
-
EMA approval · 2025-11-17EMA Authorised: Ivabradine Anpharm (ivabradine) — "Anpharm" Przedsiębiorstwo Farmaceutyczne S.A.
The European Medicines Agency authorised a new ivabradine product, Ivabradine Anpharm, by Anpharm Przedsiębiorstwo Farmaceutyczne S.A., for …
-
EMA approval · 2025-11-17EMA Authorised: Corlentor (ivabradine hydrochloride) — Les Laboratoires Servier
The EMA authorised Corlentor (ivabradine hydrochloride) for use in angina pectoris and heart failure. Les Laboratoires Servier is the market…
-
EMA approval · 2025-11-17EMA Authorised: Procoralan (ivabradine hydrochloride) — Les Laboratoires Servier
The European Medicines Agency has granted marketing authorization for Procoralan (ivabradine hydrochloride) for angina pectoris and heart fa…
-
FDA approval · 2025-11-14FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Alembic Pharmaceuticals Limited)
FDA approves the original application for diltiazem hydrochloride (Alembic Pharmaceuticals Limited), a generic product, for use in treating …
-
FDA approval · 2025-10-28FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for Nicardipine hydrochloride from Sagent Pharmaceuticals (ANDA 219608), establishing a generic produc…
-
FDA approval · 2025-10-22FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Caplin Steriles Limited)
FDA approves an original ANDA for Nicardipine Hydrochloride as a generic product by Caplin Steriles Limited.
-
FDA approval · 2025-09-19FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for verapamil hydrochloride from Amneal Pharmaceuticals LLC under ANDA210994. This approval authoriz…
-
FDA approval · 2025-09-11FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride from Actavis Pharma, Inc., confirming/expanding the product's regulatory…
-
FDA approval · 2025-08-28FDA Approved: LOPRESSOR — Original Application (VALIDUS PHARMACEUTICALS LLC)
FDA approved Lopressor (metoprolol tartrate) via the original application for METOPROLOL TARTRATE by Validus Pharmaceuticals LLC under NDA 2…
-
FDA approval · 2025-08-08FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for Diltiazem Hydrochloride by Alembic Pharmaceuticals Inc. The action represents a supplemental reg…
-
FDA approval · 2025-07-30FDA Approved: ATENOLOL — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Atenolol submitted by Rising Pharma Holdings, Inc.
-
FDA approval · 2025-07-24FDA Approved: SDAMLO — Original Application (Pangea Pharmaceuticals, LLC)
The FDA approved SDAMLO (amlodipine) under an Original Application (NDA 219531) by Pangea Pharmaceuticals, LLC.
-
EMA approval · 2025-07-17EMA Authorised: Ivabradine Zentiva (ivabradine hydrochloride) — Zentiva, k.s.
The EMA authorised Ivabradine Zentiva (ivabradine hydrochloride) for use in angina pectoris and heart failure; Marketing authorization holde…
-
FDA approval · 2025-07-14FDA Approved: ISOSORBIDE MONONITRATE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Isosorbide Mononitrate submitted by Chartwell RX, LLC. The action approves changes included in t…
-
FDA approval · 2025-07-14FDA Approved: ISOSORBIDE MONONITRATE — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for Isosorbide Mononitrate submitted by Edenbridge Pharmaceuticals LLC. The action confirms approval…
-
FDA approval · 2025-07-10FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for diltiazem hydrochloride (generic) from Sun Pharmaceutical Industries, Inc. under an ANDA. This a…
-
FDA approval · 2025-07-02FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)
FDA approved a generic diltiazem hydrochloride product from Ingenus Pharmaceuticals under an Original Application (ANDA), expanding access t…
-
FDA approval · 2025-06-25FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved NICARDIPINE HYDROCHLORIDE as a generic product under an Original Application (ANDA) from Zydus Pharmaceuticals USA Inc. This co…
-
FDA approval · 2025-06-11FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approved a supplemental application for metoprolol tartrate (Hospira, Inc.), a generic beta-blocker, confirming continued approval of th…